Stay updated on Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A site-wide notice about funding-related delays was added, and the page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-04T00:31:24.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated footer/labels to reflect QC status and version (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). Removed older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).
    Difference
    0.1%
    Check dated 2026-01-27T23:14:54.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.3.4, replacing the earlier Revision: v3.3.3. No study content, enrollment data, or results are affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T00:47:25.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Added a comprehensive Locations section listing study sites by state (Alabama through Wisconsin) with revision tag v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T09:19:18.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    The Publications section wording was updated to note that PubMed entries are automatically filled and may not all pertain to the study, and the Revision label was updated to v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-24T21:20:24.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Deleted the general notice about a lapse in government funding and potential delays in updates. The study details and links on the page remain unchanged.
    Difference
    0.1%
    Check dated 2025-11-17T18:52:28.000Z thumbnail image

Stay in the know with updates to Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial page.